Cynthia Smith - Net Worth and Insider Trading
Cynthia Smith Net Worth
The estimated net worth of Cynthia Smith is at least $69,991 dollars as of 2024-12-14. Cynthia Smith is the Director of Akebia Therapeutics Inc and owns about 37,833 shares of Akebia Therapeutics Inc (AKBA) stock worth over $69,991. Details can be seen in Cynthia Smith's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Cynthia Smith has not made any transactions after 2020-06-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Cynthia Smith
Cynthia Smith Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Cynthia Smith owns 7 companies in total, including Dicerna Pharmaceuticals Inc (DRNA) , Akebia Therapeutics Inc (AKBA) , and Spero Therapeutics Inc (SPRO) among others .
Click here to see the complete history of Cynthia Smith’s form 4 insider trades.
Insider Ownership Summary of Cynthia Smith
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DRNA | Dicerna Pharmaceuticals Inc | 2020-06-15 | director |
| AKBA | Akebia Therapeutics Inc | 2020-06-08 | director |
| SPRO | Spero Therapeutics Inc | 2019-03-19 | director |
 | | 2016-11-01 | director |
| | 2015-12-17 | Chief Commercial Officer |
| | 2021-01-29 | director |
| | 2022-08-11 | director |
Cynthia Smith Latest Holdings Summary
Cynthia Smith currently owns a total of 1 stock. Cynthia Smith owns 37,833 shares of Akebia Therapeutics Inc (AKBA) as of June 8, 2020, with a value of $69,991.
Latest Holdings of Cynthia Smith
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AKBA | Akebia Therapeutics Inc | 2020-06-08 | 37,833 | 1.85 | 69,991 |
Holding Weightings of Cynthia Smith
Cynthia Smith Form 4 Trading Tracker
According to the SEC Form 4 filings, Cynthia Smith has made a total of 1 transactions in Akebia Therapeutics Inc (AKBA) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Akebia Therapeutics Inc is the sale of 4,567 shares on June 8, 2020, which brought Cynthia Smith around $55,261.
Insider Trading History of Cynthia Smith
- 1
Cynthia Smith Trading Performance
GuruFocus tracks the stock performance after each of Cynthia Smith's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Cynthia Smith is 206.59%. GuruFocus also compares Cynthia Smith's trading performance to market benchmark return within the same time period. The performance of stocks bought by Cynthia Smith within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Cynthia Smith's insider trading performs compared to the benchmark.
Performance of Cynthia Smith
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 85.03 | | | | | |
| Relative Return to S&P 500(%) | 81.4 | | | | | |
Cynthia Smith Ownership Network
Ownership Network List of Cynthia Smith
Ownership Network Relation of Cynthia Smith
Cynthia Smith Owned Company Details
What does Dicerna Pharmaceuticals Inc do?
Who are the key executives at Dicerna Pharmaceuticals Inc?
Cynthia Smith is the director of Dicerna Pharmaceuticals Inc. Other key executives at Dicerna Pharmaceuticals Inc include See Remarks Bob D Brown , EVP & Chief Medical Officer Shreeram Aradhye , and director & President and CEO Douglas Fambrough .
Dicerna Pharmaceuticals Inc (DRNA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Dicerna Pharmaceuticals Inc (DRNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dicerna Pharmaceuticals Inc (DRNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Dicerna Pharmaceuticals Inc (DRNA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Dicerna Pharmaceuticals Inc Insider Transactions
Cynthia Smith Mailing Address
Above is the net worth, insider trading, and ownership report for Cynthia Smith. You might contact Cynthia Smith via mailing address: 508 Wrangler Drive, Suite 100, Coppell Tx 75019.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
